August 13, 2019
Pharming Acquires Late-Stage Novartis Drug to Treat Ultra-Rare Immune Disorder
Read More
August 8, 2019
Bayer Bets on Cell Therapy with Buyout of BlueRock Therapeutics
Read More
August 7, 2019
Rhythm Reports Positive Pivotal Results from Rare Obesity Trials
Read More
August 6, 2019
Allakos Reports Positive Results in Mid-Stage Study of Therapy for Rare GI Disorders
Read More
August 5, 2019
Pfizer’s Sickle Cell Treatment Fails in Late-Stage Trial
Read More
July 26, 2019
Allergan and Editas Begin First Human Trial of CRISPER-Based Gene Editing Therapy
Read More
July 2, 2019
PTC Therapeutics and Odylia Partner to Gene Therapies for Retinal Diseases
Read More
July 1, 2019
Arrowhead Gets Fast Track Designation for Alpha-1 Liver Disease Treatment
Read More
May 30, 2019
Ayala Pharmaceuticals Raises $30 Million in Novartis-Led Round
Read More
May 28, 2019
BioMarin’s Hemophilia A Gene Therapy Hits Prespecified Criteria for Regulatory Submissions
Read More
May 14, 2019
Solid Biosciences Reports Serious Adverse Event in DMD Trial
Read More
April 19, 2019
FDA Awards Breakthrough Therapy Designation to Viela Bio Treatment for Rare Autoimmune Disease
Read More
Load More
X